Is antitumour necrosis factor therapy combined with ultraviolet B phototherapy safe?

1 Brantsch K, Meisner C, Schonfisch B et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol 2008; 9:713–20. 2 Motley R, Kersey P, Lawrence C. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Dermatol 2002; 146:18–25. 3 Veness M, Palme C, Morgan G. High-risk cutaneous squamous cell carcinoma of the head and neck. Cancer 2006; 106:2389–96. 4 Clark R, Soutar D. Lymph node metastases from auricular squamous cell carcinoma. A systematic review and meta-analysis. J Plast Reconstr Aesthet Surg 2008; 61:1140–7. 5 Howle J, Morgan G, Kalning I et al. Metastatic cutaneous squamous cell carcinoma of the scalp. A NZ J Surg 2008; 78:449–53. 6 Evans R. Lymph nodes. In: Practical Head and Neck Ultrasound (Ahuja A, Evans R, eds). London: Greenwich Medical Media Ltd, 2000; 65– 82.

[1]  E. Laffitte,et al.  Giant warts in a kidney transplant patient: regression with sirolimus , 2010, The British journal of dermatology.

[2]  L. Naldi,et al.  European S3‐Guidelines on the systemic treatment of psoriasis vulgaris , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[3]  M. Lebwohl,et al.  Treatments for psoriasis and the risk of malignancy. , 2009, Journal of the American Academy of Dermatology.

[4]  K. Hemminki,et al.  Cancer risk in hospitalised psoriasis patients: a follow-up study in Sweden , 2009, British Journal of Cancer.

[5]  H. Kerl,et al.  Treatment with 311‐nm ultraviolet B accelerates and improves the clearance of psoriatic lesions in patients treated with etanercept , 2009, The British journal of dermatology.

[6]  C. Elmets,et al.  Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomes. , 2008, Journal of drugs in dermatology : JDD.

[7]  V. Werth,et al.  TNF-α production in the skin , 2008, Archives of Dermatological Research.

[8]  C. Buckley,et al.  Skin cancer in psoriatic arthritis treated with anti-TNF therapy. , 2007, Rheumatology.

[9]  F. Wolfe,et al.  Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors. , 2005, The Journal of rheumatology.

[10]  L. Dubertret,et al.  Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study. , 2003, The Journal of investigative dermatology.

[11]  R. Stern,et al.  Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study. , 1998, Journal of the National Cancer Institute.